Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(37): 1835-1837
DOI: 10.1055/s-0029-1237522
DOI: 10.1055/s-0029-1237522
Kommentar | Commentary
Gastroenterologie, Onkologie
© Georg Thieme Verlag KG Stuttgart · New York
Neoadjuvante Therapien bei gastrointestinalen Tumoren: Müssen wir umdenken?
The neoadjuvant treatment of gastrointestinal tumors: time for rethinking?Further Information
Publication History
eingereicht: 10.5.2009
akzeptiert: 23.7.2009
Publication Date:
02 September 2009 (online)
Schlüsselwörter
neoadjuvante Therapie - Chemotherapie - Radiochemotherapie - Ösophaguskarzinom - Magenkarzinom - Pankreaskarzinom - Rektumkarzinom
Keywords
neoadjuvant therapy - chemotherapy - radiochemotherapy - gastric cancer - oesophageal cancer - pancreatic cancer - rectal cancer
Literatur
- 1 Bedenne L, Michel P, Bouché O. et al . Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007; 25 1160-1168
- 2 Boige V, Pignon J, Saint-Aubert B. et al . Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE). J Clin Oncol. 2007; 25 18S
- 3 Bosset J F, Gignoux M, Triboulet J P. et al . Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997; 337 161-167
- 4 Burmeister B H, Smithers B M, Gebski V. et al . Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus. Lancet Oncol. 2005; 6 659-668
- 5 Chauffert B, Mornex F, Bonnetain F. et al . Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Ann Oncol. 2008; 19 1592-1599
- 6 Cunningham D, Allum W H, Stenning S P. et al . Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355 11-20
- 7 Imamura M, Doi R, Imaizumi T. et al . A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery. 2004; 136 1003-1011
- 8 Palmer D H, Stocken D D, Hewitt H. et al . A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol. 2007; 14 2088-2096
- 9 Sauer R, Becker H, Hohenberger W. et al . Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351 1731-1740
- 10 Stahl M, Stuschke M, Lehmann N. et al . Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005; 23 2310-2317
- 11 Stahl M, Walz M K, Stuschke M. et al . Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009; 27 851-856
- 12 Witzigmann H, Berr F, Ringel U. et al . Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma. Ann Surg. 2006; 244 230-239
Prof. Dr. M. Ebert
II. Medizinische Klinik des Klinikums rechts
der Isar, Technische Universität München
Ismaninger Str. 22
81675 München
Phone: 089/4140-4386
Fax: 089/4140-4115
Email: Matthias.Ebert@lrz.tum.de